Early research (Phase 1)Study completedNCT04316689What this trial is testingFirst-in-human Study of S-588210 (S-488210+S-488211)Who this might be right forLung CancerHead and Neck CancerBladder Cancer+2 more Shionogi 10
Early research (Phase 1)Ended earlyNCT04892017What this trial is testingStudy of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsWho this might be right forNon-Small Cell Lung CancerAdvanced Solid TumorMetastatic Solid Tumor Deciphera Pharmaceuticals, LLC 91
Early research (Phase 1)Looking for participantsNCT07181473What this trial is testingEvaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsWho this might be right forLung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more Phrontline Biopharma 200
Not applicableStudy completedNCT05230186What this trial is testingA Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.Who this might be right forSolid Tumor, Adult TScan Therapeutics, Inc. 12
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19
Testing effectiveness (Phase 2)UnknownNCT02839954What this trial is testingCAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorWho this might be right forHepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Early research (Phase 1)Looking for participantsNCT06010862What this trial is testingClinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsWho this might be right forGastric CancerColon CancerPancreas Cancer+4 more Chongqing Precision Biotech Co., Ltd 36
Not applicableLooking for participantsNCT06896162What this trial is testingPROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and SurvivalWho this might be right forSolid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more UNC Lineberger Comprehensive Cancer Center 500
Testing effectiveness (Phase 2)Study completedNCT00387322What this trial is testingPemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsWho this might be right forLung CancerUnspecified Adult Solid Tumor, Protocol Specific University of California, Davis 42
Early research (Phase 1)Active Not RecruitingNCT07118176What this trial is testingDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersWho this might be right forAnal CarcinomaBladder CarcinomaBreast Carcinoma+31 more Jonsson Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)WithdrawnNCT06681870What this trial is testingASP1893 in Adults With Advanced CLDN6-positive Solid TumorsWho this might be right forCLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more Astellas Pharma Global Development, Inc.
Early research (Phase 1)Active Not RecruitingNCT05143970What this trial is testingFirst-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsWho this might be right forMetastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more Institut Paoli-Calmettes 27
Early research (Phase 1)Study completedNCT01478685What this trial is testingCC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsWho this might be right forUrinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more Celgene 169
Not applicableUnknownNCT00710632What this trial is testingScreening to Predict Weight Loss in Patients With CancerWho this might be right forCachexiaGastrointestinal CancerHematopoietic/Lymphoid Cancer+2 more Queen's Medical Center 220
Not applicableEnded earlyNCT04106167What this trial is testingLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyWho this might be right forAdvanced Solid TumorLymphomaGastric Cancer+15 more Fate Therapeutics 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811What this trial is testingMyeloprotection With Trilaciclib in Pan-cancer PopulationWho this might be right forNon-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more Sun Yat-sen University 132
Testing effectiveness (Phase 2)Looking for participantsNCT05144698What this trial is testingRAPA-201 Therapy of Solid TumorsWho this might be right forSolid TumorSmall Cell and Non-small Cell Lung CancerHead and Neck Cancer+6 more Rapa Therapeutics LLC 37
Testing effectiveness (Phase 2)UnknownNCT05278364What this trial is testingPhase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid TumorWho this might be right forNon-Small Cell Lung CancerMedullary Thyroid CancerSolid Tumor Shouyao Holdings (Beijing) Co. LTD 184